Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlanbia Regulatory News (GLB)

Share Price Information for Glanbia (GLB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.20
Bid: 17.30
Ask: 19.10
Change: -0.23 (-1.25%)
Spread: 1.80 (10.405%)
Open: 18.43
High: 0.00
Low: 0.00
Prev. Close: 18.43
GLB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Glanbia increases and extends EUR50m share buyback

4 May 2023 07:05

RNS Number : 3487Y
Glanbia PLC
04 May 2023
 

Glanbia increases and extends existing €50m share buy-back of up to €50m to €100m

4 May 2023, Glanbia plc, the better nutrition company, (the "Company" or the "Group") announces that it has increased and extended its existing share buy-back programme of up to €50 million to up to €100m in total value in Glanbia plc ordinary shares ("Shares"). The purpose of the increased and extended buy-back programme is to further reduce the share capital of the Company (any Shares repurchased for this purpose will be cancelled).

Details of the programme 

The Company has entered into an agreement with J&E Davy ("Davy") to act as principal in relation to the purchase of the Company's Shares, within certain pre-set parameters.

The increased and extended programme will run from 4 May 2023, through to 30 September 2023, unless otherwise terminated in accordance with the Company's agreement with Davy and prevailing authority.

Under the terms of the agreement, Davy will make purchases of the Shares under the buy-back programme independently of, and uninfluenced by, the Company. Purchases may continue during any closed period to which the Company is subject. The Company confirms that it currently has no unpublished inside information.

The increased and extended share buy-back programme will be conducted within the limitations of the Company's general authority to repurchase Shares, and conditional upon the passing of Resolution 10 proposed to be approved by the Company's shareholders at the 2023 Annual General Meeting to be held today, 4 May 2023, up to a maximum of 10% of the issued share capital of the Company as at 3 March 2023, being 27,228,736 Shares.

The programme will be conducted in accordance with Chapter 9 of the Euronext Dublin Listing Rules and the relevant provisions of the Market Abuse Regulation 596/2014/EU and the Commission Delegated Regulation (EU) 2016/1052 (also as in force in the United Kingdom ("UK"), from time to time, including, where relevant, pursuant to the UK's Market Abuse (Amendment) (EU Exit) Regulations 2019) as well as the rules of the Central Bank of Ireland.

ENDS

For further information contact:

Glanbia plc +353 56 777 2200 

Mark Garvey, Group Finance Director

Liam Hennigan, Group Secretary & Head of Investor Relations: +353 86 046 8375

Martha Kavanagh, Head of Corporate Communications: +353 87 646 2006 

Davy

Ivan Murphy/Ronan Veale +353 1 679 7788

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSUOUAROWUVRUR
Date   Source Headline
26th Jul 20127:00 amRNSGlanbia acquires US beverage manufacturer
26th Jun 20127:00 amRNSUpdate on proposed joint venture
29th May 201210:14 amRNSDirectorate Change
17th May 20122:15 pmRNSDisposal
9th May 20123:19 pmRNSResult of AGM
9th May 201211:00 amRNSInterim Management Statement
23rd Apr 20123:06 pmRNSAnnual Information Update
5th Apr 20124:48 pmRNS2011 Annual Report
27th Mar 20124:35 pmRNSPrice Monitoring Extension
21st Mar 20125:00 pmRNSBlocklisting Interim Review
29th Feb 20127:00 amRNSFinal Results
21st Feb 20124:31 pmRNSHolding(s) in Company
5th Jan 20125:36 pmRNSHolding(s) in Company
22nd Dec 20112:16 pmRNSStatement re 2012 Annual General Meeting
30th Nov 20114:40 pmRNSSecond Price Monitoring Extn
30th Nov 20114:35 pmRNSPrice Monitoring Extension
16th Nov 20117:00 amRNSInterim Management Statement
9th Nov 20115:52 pmRNSDirector/PDMR Shareholding
24th Oct 20112:09 pmRNSDirector/PDMR Shareholding
7th Oct 20114:20 pmRNSDirector/PDMR Shareholding
21st Sep 20113:23 pmRNSBlocklisting Interim Review
16th Sep 201111:18 amRNSHolding(s) in Company
16th Sep 201111:15 amRNSHolding(s) in Company
15th Sep 20115:32 pmRNSDirector/PDMR Shareholding
14th Sep 20115:34 pmRNSDirector/PDMR Shareholding
12th Sep 20115:05 pmRNSDirector/PDMR Shareholding
5th Sep 20112:52 pmRNSDirector/PDMR Shareholding
2nd Sep 20117:00 amRNSMain Securities Market Notice
1st Sep 201112:39 pmRNSDirector/PDMR Shareholding
31st Aug 20119:45 amRNSUSD325 million private placement
30th Aug 20112:39 pmRNSBlocklisting
24th Aug 20117:00 amRNSHalf Yearly Report
30th Jun 20117:00 amRNSHalf Year Trading Statement
26th May 201112:21 pmRNSDirectorate Change
13th May 20114:44 pmRNSDirector/PDMR Shareholding
11th May 20113:23 pmRNSResult of AGM
11th May 20117:00 amRNSInterim Management Statement
18th Apr 20114:40 pmRNSSecond Price Monitoring Extn
18th Apr 20114:35 pmRNSPrice Monitoring Extension
12th Apr 201110:08 amRNSAnnual Information Update
6th Apr 20114:45 pmRNS2010 Annual Report
31st Mar 20115:10 pmRNSDirector/PDMR Shareholding
31st Mar 201111:12 amRNSTotal Voting Rights
29th Mar 20114:38 pmRNSDirector/PDMR Shareholding
21st Mar 20114:48 pmRNSBlocklisting Interim Review
11th Mar 201112:10 pmRNSDirector/PDMR Shareholding
2nd Mar 20113:28 pmRNSDirector/PDMR Shareholding
2nd Mar 20117:00 amRNSFinal Results
19th Jan 20117:00 amRNSGlanbia acquires US nutrition business
19th Jan 20117:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.